Old Mission Capital LLC Legend Biotech Corp Transaction History

Old Mission Capital LLC

  • $3.51 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$55.06 - $69.99 $498,788 - $634,039
9,059 Added 175.19%
14,230 $798,000
Q4 2023

Feb 14, 2024
BUY
$57.25 - $69.74 $17,060 - $20,782
298 Added 6.12%
5,171 $311,000
Q3 2023

Nov 14, 2023
BUY
$63.16 - $76.5 $23,306 - $28,228
369 Added 8.19%
4,873 $327,000
Q2 2023

Aug 09, 2023
BUY
$46.28 - $75.01 $208,445 - $337,845
4,504 New
4,504 $310,000
Q3 2022

Nov 14, 2022
BUY
$38.15 - $57.1 $307,489 - $460,226
8,060 New
8,060 $329,000

Others Institutions Holding LEGN

# of Institutions
212
Shares Held
77.9M
Call Options Held
412K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email